Alerts will be sent to your verified email
Verify EmailKOBO
Kobo Biotech
|
Zyden Gentec
|
Ganga Pharma.
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-1.77 % | -24.76 % | 1.2 % |
5yr average Equity Multiplier
|
4.06 | 2.0 | 1.4 |
5yr Average Asset Turnover Ratio
|
0.54 | 0.21 | 0.33 |
5yr Avg Net Profit Margin
|
-3.79 % | -137.59 % | 2.35 % |
Price to Book
|
0.0 | n/a | 0.0 |
P/E
|
0.0 | n/a | 91.77 |
5yr Avg Cash Conversion Cycle
|
0.0 | 785.76 Days | 183.46 Days |
Inventory Days
|
89.28 Days | 134.34 Days | 158.14 Days |
Days Receivable
|
0.0 | 803.05 Days | 120.91 Days |
Days Payable
|
147.48 Days | 421.99 Days | 141.14 Days |
5yr Average Interest Coverage Ratio
|
0.99 | -2.08 | 1.42 |
5yr Avg ROCE
|
11.79 % | -6.92 % | 4.7 % |
5yr Avg Operating Profit Margin
|
8.83 % | -95.87 % | 3.58 % |
5 yr average Debt to Equity
|
1.62 | 0.68 | 0.3 |
5yr CAGR Net Profit
|
n/a | -1.66 % | -23.43 % |
5yr Average Return on Assets
|
-0.89 % | -15.88 % | 0.85 % |
Shareholdings
|
|||
Promoter Holding
|
44.95 % | 0.0 | 56.02 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -17.28 % | -10.69 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Kobo Biotech
|
Zyden Gentec
|
Ganga Pharma.
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|